- Home
- EYPT vs ORC Comparison
EYPT vs ORC Comparison
Compare EYPT & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- ORC
- Stock Information
- Founded
- EYPT 1987
- ORC 2010
- Country
- EYPT United States
- ORC United States
- Employees
- EYPT N/A
- ORC N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- ORC Real Estate Investment Trusts
- Sector
- EYPT Industrials
- ORC Real Estate
- Exchange
- EYPT Nasdaq
- ORC Nasdaq
- Market Cap
- EYPT 741.0M
- ORC 660.1M
- IPO Year
- EYPT 2005
- ORC 2013
- Fundamental
- Price
- EYPT $13.76
- ORC $7.09
- Analyst Decision
- EYPT Strong Buy
- ORC Hold
- Analyst Count
- EYPT 6
- ORC 2
- Target Price
- EYPT $25.83
- ORC N/A
- AVG Volume (30 Days)
- EYPT 823.7K
- ORC 4.4M
- Earning Date
- EYPT 11-06-2025
- ORC 10-23-2025
- Dividend Yield
- EYPT N/A
- ORC 20.32%
- EPS Growth
- EYPT N/A
- ORC N/A
- EPS
- EYPT N/A
- ORC 0.07
- Revenue
- EYPT $51,898,000.00
- ORC $24,257,000.00
- Revenue This Year
- EYPT N/A
- ORC $68.67
- Revenue Next Year
- EYPT N/A
- ORC $51.70
- P/E Ratio
- EYPT N/A
- ORC $99.96
- Revenue Growth
- EYPT 2.99
- ORC N/A
- 52 Week Low
- EYPT $3.91
- ORC $5.69
- 52 Week High
- EYPT $14.42
- ORC $9.01
- Technical
- Relative Strength Index (RSI)
- EYPT 66.97
- ORC 47.41
- Support Level
- EYPT $12.88
- ORC $7.12
- Resistance Level
- EYPT $14.15
- ORC $7.22
- Average True Range (ATR)
- EYPT 0.76
- ORC 0.11
- MACD
- EYPT 0.02
- ORC -0.00
- Stochastic Oscillator
- EYPT 79.11
- ORC 38.57
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.